Implications of the exposome and its applicability in clinical and epidemiological studies

Stephen Rappaport (Berkeley, United States of America)

Source: International Congress 2016 – Genetics, epigenetics and the exposome
Session: Genetics, epigenetics and the exposome
Session type: Hot topics
Number: 4522

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Stephen Rappaport (Berkeley, United States of America). Implications of the exposome and its applicability in clinical and epidemiological studies. International Congress 2016 – Genetics, epigenetics and the exposome

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Common pitfalls in planning and conducting epidemiological and clinical research
Source: Annual Congress 2008 - PG10 - Getting it right – planning, realising, analysing and publishing research projects
Year: 2008



Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007


Models of translating clinical research into practice
Source: Annual Congress 2008 - MP6 - Role of allied respiratory professionals in clinical research
Year: 2008

Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019


Limitations of the current data and clinical perspectives
Source: International Congress 2016 – Is sleep apnoea causing cancer?
Year: 2016


Overview on diagnostic studies
Source: ERS Course 2015
Year: 2015



ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies
Source: Virtual Congress 2020 – New developments in pandemic medicine
Year: 2020


What requirements should a biomarker meet to be used in the clinical and epidemiological setting?
Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies
Year: 2008


Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2012; 39: 1277-1278
Year: 2012


Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2012; 39: 1278-1279
Year: 2012


Emerging concepts in outcome assessment for COPD clinical trials
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007

Future clinical perspectives
Source: International Congress 2015 – Cough: a major problem in lung disease
Year: 2015



Future clinical perspectives
Source: International Congress 2015 – PG8 Airway and lung fibrosis
Year: 2015



Opportunities and outstanding challenges for integration in clinical practice
Source: Virtual Congress 2021 – Inhale the future: ambulatory sensing technologies, digital biomarkers and explainable insights
Year: 2021


Introduction: CPET in clinical practice. Recent advances, current challenges and future directions
Source: Eur Respir Monogr 2018; 80: x-xxv
Year: 2018

Physiologic rationale and clinical pitfalls
Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure
Year: 2021


Implications of the exposome for exposure science
Source: ERS Research Seminar 2015
Year: 2015